Related references
Note: Only part of the references are listed.Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer
Patrick G. Morris et al.
CANCER PREVENTION RESEARCH (2011)
In Vitro Cytochrome P450-Mediated Metabolism of Exemestane
Landry K. Kamdem et al.
DRUG METABOLISM AND DISPOSITION (2011)
Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones
Min Lu et al.
NATURE MEDICINE (2011)
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
Irina N. Alimova et al.
CELL CYCLE (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A liquid chromatography-tandem mass spectrometry method for the simultaneous determination of exemestane and its metabolite 17-dihydroexemestane in human plasma
Giuseppe Corona et al.
JOURNAL OF MASS SPECTROMETRY (2009)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2008)
Treatment of advanced hormone-sensitive breast cancer in postmenopausal women with exemestane alone or in combination with celecoxib
Luc Yves Dirix et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cross-Talk Between the ErbB/HER Family and the Type I Insulin-Like Growth Factor Receptor Signaling Pathway in Breast Cancer
Quanri Jin et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
Residual risk of breast cancer recurrence 5 years after adjuvant therapy
Abenaa M. Brewster et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Multidisciplinary Strategy for Managing Cardiovascular Risks When Treating Patients with Early Breast Cancer
Daniel J. Lenihan et al.
ONCOLOGIST (2008)
Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer
T. A. Traina et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Anthropometric measures, plasma adiponectin, and breast cancer risk
Yu-Feng Tian et al.
ENDOCRINE-RELATED CANCER (2007)
Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS:: a randomized placebo-controlled study
A. Majuri et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Measures of response: RECIST, WHO, and new alternatives
C. Carl Jaffe
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mechanisms of disease: Estrogen carcinogenesis in breast cancer
JD Yager et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Comparative assessment of lipid effects of endocrine therapy for breast cancer: Implications for cardiovascular disease prevention in postmenopausal women
F. J. Esteva et al.
BREAST (2006)
Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer
PR Hutson et al.
CLINICAL CANCER RESEARCH (2005)
Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice
VN Anisimov et al.
EXPERIMENTAL GERONTOLOGY (2005)
Serum levels of leptin, insulin, and lipids in relation to breast cancer in China
CZ Han et al.
ENDOCRINE (2005)
Hyperinsulinaemia and increased risk of breast cancer: findings from the British women's heart and health study
DA Lawlor et al.
CANCER CAUSES & CONTROL (2004)
Effect of ketoconazole on the pharmacokinetics of rosiglitazone in healthy subjects
JY Park et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Prognostic molecular markers in early breast cancer
FJ Esteva et al.
BREAST CANCER RESEARCH (2004)
Monoclonal antibodies, small molecules, and Vaccines in the treatment of breast cancer
FJ Esteva
ONCOLOGIST (2004)
Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer
FJ Esteva et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Pharmacokinetics and dose finding of a potent aromatase inhibitor, Aromasin (exemestane), in young males
N Mauras et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Growth factor receptors in breast cancer: Potential for therapeutic intervention
R Nahta et al.
ONCOLOGIST (2003)
Molecular prognostic factors for breast cancer metastasis and survival
FJ Esteva et al.
SEMINARS IN RADIATION ONCOLOGY (2002)
Novel therapeutic approach:: ligands for PPARγ and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells
E Elstner et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women
JM Petrelli et al.
CANCER CAUSES & CONTROL (2002)
Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer
E Rivera et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus - A randomized controlled trial
V Fonseca et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
